SE8401185D0 - Osmotiskt system med omedelbar lekemedelstillgenglighet - Google Patents

Osmotiskt system med omedelbar lekemedelstillgenglighet

Info

Publication number
SE8401185D0
SE8401185D0 SE8401185A SE8401185A SE8401185D0 SE 8401185 D0 SE8401185 D0 SE 8401185D0 SE 8401185 A SE8401185 A SE 8401185A SE 8401185 A SE8401185 A SE 8401185A SE 8401185 D0 SE8401185 D0 SE 8401185D0
Authority
SE
Sweden
Prior art keywords
wall
agent
osmotic system
drug availability
immediate drug
Prior art date
Application number
SE8401185A
Other languages
English (en)
Other versions
SE8401185L (sv
SE459847B (sv
Inventor
G V Guittard
J C Deters
F Theeuwes
R Cortese
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of SE8401185D0 publication Critical patent/SE8401185D0/sv
Publication of SE8401185L publication Critical patent/SE8401185L/sv
Publication of SE459847B publication Critical patent/SE459847B/sv

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • External Artificial Organs (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE8401185A 1983-03-04 1984-03-02 Osmotiskt system med omedelbar laekemedelstillgaenglighet SE459847B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/472,333 US4576604A (en) 1983-03-04 1983-03-04 Osmotic system with instant drug availability

Publications (3)

Publication Number Publication Date
SE8401185D0 true SE8401185D0 (sv) 1984-03-02
SE8401185L SE8401185L (sv) 1984-09-05
SE459847B SE459847B (sv) 1989-08-14

Family

ID=23875096

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8401185A SE459847B (sv) 1983-03-04 1984-03-02 Osmotiskt system med omedelbar laekemedelstillgaenglighet

Country Status (22)

Country Link
US (1) US4576604A (sv)
JP (1) JPS59167513A (sv)
AT (1) AT397179B (sv)
AU (1) AU568621B2 (sv)
BE (1) BE898820A (sv)
BR (1) BR8400997A (sv)
CA (1) CA1242122A (sv)
CH (1) CH660124A5 (sv)
DE (1) DE3407873A1 (sv)
DK (1) DK162470C (sv)
ES (1) ES530268A0 (sv)
FR (1) FR2541896B1 (sv)
GB (1) GB2135880B (sv)
IE (1) IE56606B1 (sv)
IL (1) IL71112A (sv)
IT (1) IT1182253B (sv)
MX (1) MX165227B (sv)
NL (1) NL192720C (sv)
NO (1) NO170667C (sv)
NZ (1) NZ206988A (sv)
SE (1) SE459847B (sv)
ZA (1) ZA84259B (sv)

Families Citing this family (120)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU571922B2 (en) * 1984-01-26 1988-04-28 Schering Agrochemicals Limited Veterinary implants comprising melatonin and derivatives thereof
US4618487A (en) * 1984-07-06 1986-10-21 Alza Corporation Device for administering calcium ascorbate
US4769027A (en) * 1984-08-15 1988-09-06 Burroughs Wellcome Co. Delivery system
US4624847A (en) * 1985-04-22 1986-11-25 Alza Corporation Drug delivery device for programmed delivery of beneficial drug
US4786501A (en) * 1985-07-15 1988-11-22 International Minerals & Chemical Corp. Cylindrical implants for the controlled release of growth hormones
US4643731A (en) * 1985-08-16 1987-02-17 Alza Corporation Means for providing instant agent from agent dispensing system
US4698062A (en) * 1985-10-30 1987-10-06 Alza Corporation Medical device for pulsatile transdermal delivery of biologically active agents
US4898733A (en) * 1985-11-04 1990-02-06 International Minerals & Chemical Corp. Layered, compression molded device for the sustained release of a beneficial agent
US4662880A (en) * 1986-03-14 1987-05-05 Alza Corporation Pseudoephedrine, brompheniramine therapy
ES2019634B3 (es) * 1986-04-17 1991-07-01 Alza Corp Terapia con clorfeniramina.
US4857330A (en) * 1986-04-17 1989-08-15 Alza Corporation Chlorpheniramine therapy
US4842867A (en) * 1986-05-09 1989-06-27 Alza Corporation Pulsed drug delivery of doxylamine
AU601736B2 (en) * 1986-05-23 1990-09-20 Sanofi Sante Nutrition Animale Sa Coated veterinary implants
GB8626098D0 (en) * 1986-10-31 1986-12-03 Euro Celtique Sa Controlled release hydromorphone composition
DE3778662D1 (de) * 1986-11-14 1992-06-04 Ciba Geigy Ag Orales osmotisches system fuer metoprolol mit verbesserten formulierungseigenschaften.
JPS63135179A (ja) * 1986-11-26 1988-06-07 立花 俊郎 薬物の経皮投与具
US4801461A (en) 1987-01-28 1989-01-31 Alza Corporation Pseudoephedrine dosage form
US4810502A (en) * 1987-02-27 1989-03-07 Alza Corporation Pseudoephedrine brompheniramine therapy
US4915952A (en) * 1987-02-27 1990-04-10 Alza Corporation Composition comprising drug, HPC, HPMC and PEO
US5023076A (en) * 1987-02-27 1991-06-11 Alza Corporation Lamina comprising carboxyvinyl polymer
GB2206046B (en) * 1987-06-25 1991-04-03 Alza Corp Multi-unit delivery system
US4892739A (en) * 1988-04-25 1990-01-09 Ciba-Geigy Corporation Osmotic continuous dispensing oral delivery system containing a pharmaceutically acceptable active agent having a improved core membrane adhesion properties
GR1000252B (el) * 1988-09-02 1992-05-12 Alza Corp Μορφη δοσολογιας συνισταμενη απο ταχεια απελευθερωση δραστικου παραγοντα ακολουθουμενη απο βραδεια απελευθερωση δραστικου παραγοντα.
US5034229A (en) 1988-12-13 1991-07-23 Alza Corporation Dispenser for increasing feed conversion of hog
US4969884A (en) * 1988-12-28 1990-11-13 Alza Corporation Osmotically driven syringe
DK469989D0 (da) * 1989-09-22 1989-09-22 Bukh Meditec Farmaceutisk praeparat
US5200197A (en) * 1989-11-16 1993-04-06 Alza Corporation Contraceptive pill
US5045082A (en) * 1990-01-10 1991-09-03 Alza Corporation Long-term delivery device including loading dose
US5071607A (en) * 1990-01-31 1991-12-10 Alza Corporatino Method and apparatus for forming a hole in a drug dispensing device
US5221536A (en) * 1990-05-07 1993-06-22 Alza Corporation Dosage form indicated for the management of abnormal posture, tremor and involuntary movement
US5192550A (en) * 1990-05-07 1993-03-09 Alza Corporation Dosage form for treating central nervous system disorders
US5190763A (en) * 1990-05-07 1993-03-02 Alza Corporation Dosage form indicated for the management of abnormal posture, tremor and involuntary movement
US5187100A (en) * 1990-05-29 1993-02-16 Lifescan, Inc. Dispersion to limit penetration of aqueous solutions into a membrane
US5128145A (en) * 1990-06-13 1992-07-07 Alza Corporation Dosage form for Parkinson's disease, spasticity and muscle spasms
DK0542926T3 (da) * 1990-08-07 1995-05-15 Pfizer Brug af grænsefladepolymeriserede membraner i frigivelsesanordninger
US5178867A (en) * 1991-08-19 1993-01-12 Alza Corporation Dosage form for delivering drug in short-time period
US5407686A (en) * 1991-11-27 1995-04-18 Sidmak Laboratories, Inc. Sustained release composition for oral administration of active ingredient
US5429822A (en) * 1992-03-13 1995-07-04 Cambridge Scientific, Inc. Biodegradable bursting release system
US6440457B1 (en) * 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
US6080428A (en) 1993-09-20 2000-06-27 Bova; David J. Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
US20060263428A1 (en) * 1993-09-20 2006-11-23 Eugenio Cefali Methods for treating hyperlipidemia with intermediate release nicotinic acid compositions having unique biopharmaceutical characteristics
US6746691B2 (en) 1993-09-20 2004-06-08 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
US6818229B1 (en) 1993-09-20 2004-11-16 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia
US6129930A (en) 1993-09-20 2000-10-10 Bova; David J. Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
US6676967B1 (en) * 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
US5540665A (en) * 1994-01-31 1996-07-30 Alza Corporation Gas driven dispensing device and gas generating engine therefor
US5460826A (en) * 1994-06-27 1995-10-24 Alza Corporation Morphine therapy
US5672357A (en) * 1994-07-01 1997-09-30 Monsanto Company Method and device for implantation of large diameter objects in bovines
US5595752A (en) * 1994-07-01 1997-01-21 Monsanto Company Increasing dressing percentage and carcass weight in finishing beef cattle
US5529787A (en) * 1994-07-07 1996-06-25 Alza Corporation Hydromorphone therapy
US5914131A (en) * 1994-07-07 1999-06-22 Alza Corporation Hydromorphone therapy
US6491945B1 (en) * 1994-09-16 2002-12-10 Alza Corporation Hydrocodone therapy
US6283951B1 (en) 1996-10-11 2001-09-04 Transvascular, Inc. Systems and methods for delivering drugs to selected locations within the body
EP0914097B1 (en) * 1996-03-12 2002-01-16 Alza Corporation Composition and dosage form comprising opioid antagonist
US6919373B1 (en) * 1996-11-12 2005-07-19 Alza Corporation Methods and devices for providing prolonged drug therapy
US5948787A (en) * 1997-02-28 1999-09-07 Alza Corporation Compositions containing opiate analgesics
ES2203963T3 (es) * 1997-05-30 2004-04-16 Osmotica Corp. Dispositivo osmotico multicapa.
US8524277B2 (en) * 1998-03-06 2013-09-03 Alza Corporation Extended release dosage form
US20020127254A1 (en) * 1998-06-25 2002-09-12 Lavipharm Laboratories Inc. Devices for local and systemic delivery of active substance and methods of manufacturing thereof
US20090297602A1 (en) * 1998-11-02 2009-12-03 Devane John G Modified Release Loxoprofen Compositions
US6198966B1 (en) 1999-02-26 2001-03-06 Medtronic, Inc. Recirculating implantable drug delivery system
WO2000062759A1 (en) 1999-04-16 2000-10-26 Novo Nordisk A/S Dry, mouldable drug formulation
US6264973B1 (en) * 1999-08-26 2001-07-24 Fei Enterprises, Ltd. Apparatus and method for anesthetizing the cervical region of a female
CA2683185A1 (en) 2000-02-04 2001-08-09 Durect Corporation Osmotically-driven fluid dispenser and coating composition
US6464688B1 (en) 2000-02-15 2002-10-15 Microsolutions, Inc. Osmotic pump delivery system with flexible drug compartment
EP1313425B1 (en) * 2000-07-14 2007-03-07 Novo Nordisk A/S Method of moulding a pharmaceutical composition in a packaging material
ATE330586T1 (de) * 2001-03-14 2006-07-15 Pfizer Prod Inc Pharmazeutische tablette und eine verfahren zu deren herstellung
US6632217B2 (en) 2001-04-19 2003-10-14 Microsolutions, Inc. Implantable osmotic pump
CN1596100A (zh) * 2001-09-28 2005-03-16 麦克内尔-Ppc股份有限公司 可食用组合物及含可食用外壳的制剂
US20040253312A1 (en) 2001-09-28 2004-12-16 Sowden Harry S. Immediate release dosage form comprising shell having openings therein
US20030228368A1 (en) * 2001-09-28 2003-12-11 David Wynn Edible solid composition and dosage form
US7838026B2 (en) 2001-09-28 2010-11-23 Mcneil-Ppc, Inc. Burst-release polymer composition and dosage forms comprising the same
US7122143B2 (en) 2001-09-28 2006-10-17 Mcneil-Ppc, Inc. Methods for manufacturing dosage forms
US8454997B2 (en) * 2001-12-18 2013-06-04 Novo Nordisk A/S Solid dose micro implant
WO2003051328A1 (en) * 2001-12-18 2003-06-26 Novo Nordisk A/S Solid dose micro implant
PT1551372T (pt) * 2002-09-20 2018-07-23 Alpharma Pharmaceuticals Llc Subunidade de sequestração e composições e métodos relacionados
WO2004028510A1 (en) 2002-09-28 2004-04-08 Mcneil-Ppc, Inc. Delayed release dosage forms
US20070077301A1 (en) * 2002-12-23 2007-04-05 Meyer Glenn A Venlafaxine osmotic device formulation
US8029822B2 (en) * 2003-05-22 2011-10-04 Osmotica Kereskedelmi és Seolgáltató KFT Rupturing controlled release device having a preformed passageway
CN103788089A (zh) * 2003-09-17 2014-05-14 詹森药业有限公司 作为血清素受体调节剂的稠合杂环化合物
KR20060092255A (ko) * 2003-09-26 2006-08-22 알자 코포레이션 고도의 약물적재를 제공하는 약물코팅제 및 그의 제조방법
AU2004275816A1 (en) * 2003-09-26 2005-04-07 Alza Corporation Controlled release formulations of opioid and nonopioid analgesics
MXPA06003452A (es) * 2003-09-26 2006-08-31 Johnson & Johnson Formulaciones de liberacion controlada que exhiben una velocidad de liberacion ascendente.
MXPA06003453A (es) * 2003-09-26 2006-08-31 Johnson & Johnson Barra de empuje oros para el suministro controlado de agentes activos.
US20050129764A1 (en) * 2003-12-11 2005-06-16 Vergez Juan A. Osmotic device containing licofelone
US7879354B2 (en) 2004-01-13 2011-02-01 Mcneil-Ppc, Inc. Rapidly disintegrating gelatinous coated tablets
US8067029B2 (en) 2004-01-13 2011-11-29 Mcneil-Ppc, Inc. Rapidly disintegrating gelatinous coated tablets
US20050196447A1 (en) * 2004-03-05 2005-09-08 Huang Hai Y. Polymeric compositions and dosage forms comprising the same
US20050196442A1 (en) * 2004-03-05 2005-09-08 Huang Hai Y. Polymeric compositions and dosage forms comprising the same
US20050196448A1 (en) * 2004-03-05 2005-09-08 Hai Yong Huang Polymeric compositions and dosage forms comprising the same
US20050196446A1 (en) * 2004-03-05 2005-09-08 Huang Hai Y. Polymeric compositions and dosage forms comprising the same
US8541026B2 (en) 2004-09-24 2013-09-24 Abbvie Inc. Sustained release formulations of opioid and nonopioid analgesics
WO2006052742A2 (en) * 2004-11-05 2006-05-18 Smithkline Beecham Corporation Pharmaceutical analysis apparatus and method
US20060104931A1 (en) * 2004-11-12 2006-05-18 Takeshi Fukutome Cosmetic treatment article comprising substrate and gel composition
AR053986A1 (es) 2004-12-03 2007-05-30 Osmotica Pharmaceutical Argent Dispositivo osmotico que contiene amantadina y una sal osmotica
US7530804B2 (en) * 2004-12-07 2009-05-12 Mcneil-Ppc, Inc. System and process for providing at least one opening in dosage forms
US20060233882A1 (en) * 2005-04-15 2006-10-19 Sowden Harry S Osmotic dosage form
US8673352B2 (en) * 2005-04-15 2014-03-18 Mcneil-Ppc, Inc. Modified release dosage form
RU2408368C2 (ru) 2005-06-27 2011-01-10 Биовэйл Лэборэториз Интернэшнл С.Р.Л. Препараты соли бупропиона с модифицированным высвобождением
US7598255B2 (en) * 2005-08-04 2009-10-06 Janssen Pharmaceutica Nv Pyrimidine compounds as serotonin receptor modulators
WO2007073702A2 (es) 2005-12-29 2007-07-05 Osmotica Corp. Comprimido multicapa con combinación de triple liberación
US20090069343A1 (en) * 2006-04-10 2009-03-12 Dunford Paul J Combination Histamine H1R and H4R Antagonist Therapy for Treating Pruritus
US8137327B2 (en) * 2006-06-16 2012-03-20 Family Health International Vaginal drug delivery system and method
US8158156B2 (en) * 2006-06-19 2012-04-17 Alpharma Pharmaceuticals, Llc Abuse-deterrent multi-layer pharmaceutical composition comprising an opioid antagonist and an opioid agonist
AU2007275033A1 (en) * 2006-07-21 2008-01-24 Lab International Srl Hydrophobic abuse deterrent delivery system
US20100151014A1 (en) * 2008-12-16 2010-06-17 Alpharma Pharmaceuticals, Llc Pharmaceutical composition
US8623418B2 (en) * 2007-12-17 2014-01-07 Alpharma Pharmaceuticals Llc Pharmaceutical composition
AU2008346870A1 (en) * 2007-12-17 2009-07-16 Alpharma Pharmaceuticals, Llc Pharmaceutical composition
US20090311335A1 (en) * 2008-06-12 2009-12-17 Scott Jenkins Combination of a triptan and an nsaid
CA2736899C (en) 2008-09-25 2016-08-30 Isp Investments Inc. Smooth, high solids tablet coating composition
DE102008059206A1 (de) * 2008-11-27 2010-06-10 Bayer Schering Pharma Aktiengesellschaft Pharmazeutische Darreichungsform enthaltend Nifedipin oder Nisoldipin und einen Angiotensin-II Antagonisten und/oder ein Diuretikum
JP2012523428A (ja) * 2009-04-09 2012-10-04 アルカーメス ファーマ アイルランド リミテッド 放出制御クロザピン組成物
AU2013258273A1 (en) 2012-05-07 2014-11-13 Bayer Pharma Aktiengesellschaft Process for manufacturing a pharmaceutical dosage form comprising nifedipine and candesartan cilexetil
JP7064285B2 (ja) 2013-12-06 2022-05-10 デュレクト コーポレーション 抗酸化剤を含む組成物、流体分注器、及びそれらに関わる方法
WO2017168174A1 (en) 2016-04-02 2017-10-05 N4 Pharma Uk Limited New pharmaceutical forms of sildenafil
WO2018002673A1 (en) 2016-07-01 2018-01-04 N4 Pharma Uk Limited Novel formulations of angiotensin ii receptor antagonists
WO2018115888A1 (en) 2016-12-21 2018-06-28 N4 Pharma Uk Limited Novel formulations of aprepitant
US9707217B1 (en) 2017-02-03 2017-07-18 Osmotica Kereskedelmi Es Szolgaltato Kft Dose-dumping resistant controlled release dosage form
CA3236068A1 (en) 2017-07-10 2019-01-17 Gel Cap Technologies, LLC Dual release dosage form capsule and methods, devices and systems for making same
WO2019023617A1 (en) * 2017-07-27 2019-01-31 University Of Utah Research Foundation DEVICE FOR DELIVERY OF THERAPEUTIC PRODUCT

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2099402A (en) * 1934-01-17 1937-11-16 Pratt Food Company Pill or tablet
US2921001A (en) * 1957-04-16 1960-01-12 Sterling Drug Inc Multi-layered pill or tablet with indicating lamination
US3577512A (en) * 1968-10-11 1971-05-04 Nat Patent Dev Corp Sustained release tablets
US3625214A (en) * 1970-05-18 1971-12-07 Alza Corp Drug-delivery device
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
AU466503B2 (en) * 1972-06-05 1975-10-30 Alza Corporation Osmotic dispenser
US4135514A (en) * 1974-12-23 1979-01-23 Alza Corporation Osmotic releasing system for administering ophthalmic drug to eye of animal
US4093709A (en) * 1975-01-28 1978-06-06 Alza Corporation Drug delivery devices manufactured from poly(orthoesters) and poly(orthocarbonates)
US4014334A (en) * 1976-02-02 1977-03-29 Alza Corporation Laminated osmotic system for dispensing beneficial agent
US4122157A (en) * 1977-03-04 1978-10-24 Richardson-Merrell Inc. Nitrofurantoin sustained release tablet
US4256108A (en) * 1977-04-07 1981-03-17 Alza Corporation Microporous-semipermeable laminated osmotic system
US4200098A (en) * 1978-10-23 1980-04-29 Alza Corporation Osmotic system with distribution zone for dispensing beneficial agent
US4309996A (en) * 1980-04-28 1982-01-12 Alza Corporation System with microporous releasing diffusor
JPS5839618A (ja) * 1981-09-04 1983-03-08 Chugai Pharmaceut Co Ltd 持続性積層錠剤
US4455143A (en) * 1982-03-22 1984-06-19 Alza Corporation Osmotic device for dispensing two different medications

Also Published As

Publication number Publication date
SE8401185L (sv) 1984-09-05
IT1182253B (it) 1987-10-05
AT397179B (de) 1994-02-25
AU568621B2 (en) 1988-01-07
US4576604A (en) 1986-03-18
IL71112A0 (en) 1984-05-31
JPS644489B2 (sv) 1989-01-25
CA1242122A (en) 1988-09-20
NO170667C (no) 1992-11-18
DE3407873A1 (de) 1984-09-06
DK88884D0 (da) 1984-02-22
BE898820A (fr) 1984-05-30
NL192720B (nl) 1997-09-01
FR2541896A1 (fr) 1984-09-07
BR8400997A (pt) 1984-10-09
DK162470C (da) 1992-04-06
IL71112A (en) 1986-09-30
ES8503499A1 (es) 1985-03-01
IT8467204A0 (it) 1984-03-02
NL8400670A (nl) 1984-10-01
ZA84259B (en) 1985-02-27
IE56606B1 (en) 1991-10-09
FR2541896B1 (fr) 1987-07-24
SE459847B (sv) 1989-08-14
DE3407873C2 (sv) 1992-10-08
GB2135880B (en) 1986-10-01
ATA72784A (de) 1993-07-15
MX165227B (es) 1992-10-30
DK162470B (da) 1991-11-04
ES530268A0 (es) 1985-03-01
GB8400563D0 (en) 1984-02-15
JPS59167513A (ja) 1984-09-21
IE840156L (en) 1984-09-04
DK88884A (da) 1984-09-05
NO170667B (no) 1992-08-10
AU2306884A (en) 1984-09-06
NL192720C (nl) 1998-01-06
NO840725L (no) 1984-09-05
NZ206988A (en) 1986-04-11
CH660124A5 (de) 1987-03-31
GB2135880A (en) 1984-09-12

Similar Documents

Publication Publication Date Title
SE8401185D0 (sv) Osmotiskt system med omedelbar lekemedelstillgenglighet
SE8402512D0 (sv) Osmotisk avgivningsanordning med dubbel termodynamisk verkan
NO911260L (no) Utleveringssystem for aromastoff og soetningsmiddel, samt fremgangsmaate for fremstilling av et slikt system.
DK588487A (da) Forbedrede metalholdige farmaceutiske midler
NO872412L (no) Fremgangsmaate og anordning til avgivelse av et middel i et biologisk miljoe.
FI930862A0 (fi) En doseringsform foer tidsvarierande moenster av laekemedeloeverlaotelse
NO900990D0 (no) Systemer for lagring og utlevering av gass.
AU2017488A (en) Antifoam agents
GR3006630T3 (sv)
NL187144C (nl) Inbouwapparaat met ingesneden bevestigingshuls en bevestigingshuls voor een dergelijk inbouwapparaat.
IT8920474A0 (it) Procedimento e dispositivo per la determinazione del diametro di sigarette.
DE3880480D1 (de) Hemolyse-inhibitor und plastifizierungsmittel.
DE3279952D1 (en) Static, dynamic and mechanical suction device for gases
IT1207040B (it) Sistema per l'immagazzinamento e la presentazione di oggetti.
IL88123A0 (en) Device for the pulsed delivery of an irrigation liquid,and irrigation facilities incorporating the same device
DE68910366D1 (de) Schaummittel.
ES2078976T3 (es) Dosificador que comprende un tonoforo.
NO883685D0 (no) Utpressingsfremgangsmaate og -apparat.
DK564284D0 (da) Pyrazinonderivater, fremgangsmaader til fremstilling deraf samt farmaceutiske midler indeholdende disse
DE3862725D1 (de) Gas- und fluessigkeitsdichte verbindung i.
SE8500928D0 (sv) Forfarande for haltagning genom en behallares vegg och redskap avsett att anvendas i samband dermed
IT8783512A0 (it) Di apertura. valigetta perfezionata nel sistema
SU1197464A1 (ru) Устройство для поддержания давления в резервуаре
NO902483D0 (no) Kombinert ror- og propellinnretning.
NO159217C (no) Innretning for reduksjon av spredningen i treffbilde for en ammunisjonsenhet.

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8401185-7

Format of ref document f/p: F

NUG Patent has lapsed